Mobia Medical (NASDAQ:MOBI) Releases Earnings Results

Mobia Medical (NASDAQ:MOBI) issued its quarterly earnings results on Thursday. The company reported $999.00 EPS for the quarter, reports.

Mobia Medical Stock Up 0.8%

MOBI stock traded up $0.11 during midday trading on Thursday, reaching $13.84. 240,618 shares of the company’s stock traded hands, compared to its average volume of 173,512. The stock has a market cap of $457.90 million, a price-to-earnings ratio of 66.00 and a beta of 2.84. Mobia Medical has a fifty-two week low of $10.19 and a fifty-two week high of $14.77.

Analysts Set New Price Targets

Several research firms recently issued reports on MOBI. JPMorgan Chase & Co. began coverage on shares of Mobia Medical in a research report on Tuesday. They issued an “overweight” rating and a $15.00 target price on the stock. BTIG Research began coverage on shares of Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $19.00 target price on the stock. Bank of America began coverage on shares of Mobia Medical in a research report on Tuesday. They issued a “buy” rating and a $16.00 target price on the stock. Wall Street Zen raised shares of Mobia Medical to a “hold” rating in a research report on Saturday, May 16th. Finally, Wolfe Research initiated coverage on shares of Mobia Medical in a research report on Tuesday. They set an “outperform” rating on the stock. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $20.25.

Insider Activity

In other Mobia Medical news, Director Casey M. Tansey purchased 66,666 shares of Mobia Medical stock in a transaction on Monday, May 11th. The shares were purchased at an average cost of $15.00 per share, with a total value of $999,990.00. Following the completion of the transaction, the director directly owned 233,332 shares in the company, valued at approximately $3,499,980. This represents a 40.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William T. Harrington purchased 533,333 shares of Mobia Medical stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. Following the completion of the transaction, the director owned 2,006,716 shares of the company’s stock, valued at $30,100,740. This represents a 36.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired a total of 1,268,332 shares of company stock valued at $19,024,980 over the last quarter.